These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37186102)

  • 1. COVID-19 vaccine-associated vitiligo: A cross-sectional study in a tertiary referral center and systematic review.
    Tsai TF; Ng CY
    J Dermatol; 2023 Aug; 50(8):982-989. PubMed ID: 37186102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Various aspects of the relationship between vitiligo and the COVID-19 pandemic or SARS-CoV-2 vaccines: Clinical pearls for dermatologists.
    Aryanian Z; Balighi K; Hatami P; Goodarzi A; Janbakhsh A; Afshar ZM
    J Cosmet Dermatol; 2023 Apr; 22(4):1152-1156. PubMed ID: 36762373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Facial Vitiligo After SARS-CoV-2 Vaccination].
    Flores-Terry MÁ; García-Arpa M; Santiago-Sánchez Mateo JL; Romero Aguilera G
    Actas Dermosifiliogr; 2022; 113(7):721. PubMed ID: 35221340
    [No Abstract]   [Full Text] [Related]  

  • 4. Demographic and clinical feature disparity between progress and non-progress patients with vitiligo after COVID-19 vaccination: A cross-sectional study.
    Hou X; Wu N; Xu M; Kharel P; Wu F; Wu Y; Wang R; Chen J
    Exp Dermatol; 2023 Sep; 32(9):1344-1349. PubMed ID: 37140178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new-onset vitiligo following the inactivated COVID-19 vaccine.
    Koç Yıldırım S
    J Cosmet Dermatol; 2022 Feb; 21(2):429-430. PubMed ID: 34910371
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID Vaccine-Associated Uveitis.
    Habot-Wilner Z; Neri P; Okada AA; Agrawal R; Xin Le N; Cohen S; Fischer N; Kilmartin F; Coman A; Kilmartin D
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1198-1205. PubMed ID: 37145198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into new-onset autoimmune diseases after COVID-19 vaccination.
    Guo M; Liu X; Chen X; Li Q
    Autoimmun Rev; 2023 Jul; 22(7):103340. PubMed ID: 37075917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo following the COVID-19 Vaccination and Infection.
    Green M; Feschuk A; Kashetsky N; Maibach HI
    Skinmed; 2023; 21(3):213-216. PubMed ID: 37634112
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune adverse event following COVID-19 vaccination in Seoul, South Korea.
    Kim HJ; Kim MH; Park SJ; Choi MG; Chun EM
    J Allergy Clin Immunol; 2024 Jun; 153(6):1711-1720. PubMed ID: 38520423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo worsened following the second dose of mRNA SARS-CoV-2 vaccine.
    Caroppo F; Deotto ML; Tartaglia J; Belloni Fortina A
    Dermatol Ther; 2022 Jun; 35(6):e15434. PubMed ID: 35266259
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 vaccinations: The unknowns, challenges, and hopes.
    Mohamed K; Rzymski P; Islam MS; Makuku R; Mushtaq A; Khan A; Ivanovska M; Makka SA; Hashem F; Marquez L; Cseprekal O; Filgueiras IS; Fonseca DLM; Mickael E; Ling I; Arero AG; Cuschieri S; Minakova K; Rodríguez-Román E; Abarikwu SO; Faten AB; Grancini G; Cabral-Marques O; Rezaei N
    J Med Virol; 2022 Apr; 94(4):1336-1349. PubMed ID: 34845731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review.
    Almas T; Rehman S; Mansour E; Khedro T; Alansari A; Malik J; Alshareef N; Nagarajan VR; Al-Awaid AH; Alsufyani R; Alsufyani M; Rifai A; Alzahrani A; Nagarajan DR; Abdullatif T; Gunasaegaram V; Alzadjali E; Subramanian A; Rahman A; Sattar Y; Galo J; Virk HUH; Alraies MC
    Biomed Pharmacother; 2022 May; 149():112843. PubMed ID: 35325848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Covid-19 mRNA vaccine on serum anti-Müllerian hormone levels.
    Mohr-Sasson A; Haas J; Abuhasira S; Sivan M; Doitch Amdurski H; Dadon T; Blumenfeld S; Derazne E; Hemi R; Orvieto R; Afek A; Rabinovici J
    Hum Reprod; 2022 Mar; 37(3):534-541. PubMed ID: 34935913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
    Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
    Front Immunol; 2022; 13():956825. PubMed ID: 36177033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in willingness to COVID-19 vaccination in China: Two online surveys during the pandemic.
    Huang N; Wang C; Han B; Zhao T; Liu B; Chen L; Xie M; Zheng H; Zhang S; Wang Y; Juan D; Liu Y; Lu Q; Cui F
    J Med Virol; 2022 Nov; 94(11):5271-5278. PubMed ID: 35848516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine.
    Okan G; Vural P
    Dermatol Ther; 2022 Mar; 35(3):e15280. PubMed ID: 34931408
    [No Abstract]   [Full Text] [Related]  

  • 18. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
    Jarius S; Bieber N; Haas J; Wildemann B
    J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-onset autoimmune phenomena post-COVID-19 vaccination.
    Chen Y; Xu Z; Wang P; Li XM; Shuai ZW; Ye DQ; Pan HF
    Immunology; 2022 Apr; 165(4):386-401. PubMed ID: 34957554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden onset of vitiligo after COVID-19 vaccine.
    Ciccarese G; Drago F; Boldrin S; Pattaro M; Parodi A
    Dermatol Ther; 2022 Jan; 35(1):e15196. PubMed ID: 34751491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.